Peptides

AOD-9604

A fragment peptide studied for fat metabolism signaling

  • Page Sections
Quickstart
Interactive Guide
Protocol
Notes
Links
  • Other Peptides

LL-37

ARA-290

Tirzepatide

Thymosin Alpha 1

Tesamorelin with Ipamorelin

Tesamorelin

TB-500 (Thymosin Beta-4)

TA1 Complex Wtih Thymalin

SS-31

Semax

Semaglutide

Selank

Retatrutide

PT-141

NAD+

MOTS-C

Melanotan-2

L-Glutathione

KPV

Kisspeptin

Ipamorelin

IGF-LR3

GLOW 50/10/10mg

GHK-Cu

Epithalon

DSIP

CJC-1295 with Ipamorelin

CJC-1295 with DAC

CJC-1295

GHRP-2

BPC-157

Wolverine

AOD-9604

  • Quickstart Highlights
AOD-9604

AOD-9604 is a peptide fragment derived from human growth hormone and is studied for its role in lipid metabolism and fat-related signaling pathways. Research focuses on how this fragment may influence metabolic processes without engaging the full growth hormone axis.

  • Interactive Guide for reconstitution and Dosing
Amount in vial
Syringe size
Water to mix
Total water (mL)
4 mL
Dosage per unit
Peptide per 0.01 mL
25 mcg per unit (0.01 mL)
Recommended dose
Suggested starting dose
300 mcg
Units to draw
Based on selected syringe size
12 units
Visual results
Draw — units
  • Dosing Protocol
  • Recommend starting dose

300 mcg

  • Recommend target dose

500 mcg

  • Protocol duration

8–12 weeks

  • Dosing Frequency

Once per day

  • Injection Method

Subcutaneous

  • Time of day

Morning (fasted)

  • Important Notes
  • Multiple studies indexed by the US National Library of Medicine (PubMed) explore AOD-9604’s interaction with fat metabolism and adipose tissue signaling.
  • Research has examined its effects on lipolytic pathways without the growth-promoting activity of full HGH.
  • Human and animal studies have focused on mechanism of action, safety, and metabolic outcomes rather than cosmetic weight loss claims.
  • Additional Information

Journal of Endocrinology and Metabolism (2014)

Safety and metabolism of AOD9604 as a nutraceutical ingredient; mechanism of action and metabolic studies

Metabolic Studies of AOD-9604

Peer-reviewed preclinical research on metabolic actions of AOD-9604 in animal models

AOD-9604 Effects on Lipid Metabolism

Research detailing the effects of AOD-9604 and GH fragment on body weight and fat metabolism.

AOD-9604 Metabolic & Clinical Overview

Article noting clinical development and phase II studies for obesity treatment.

Detection and Metabolism of AOD-9604

Molecular and detection study published on PubMed

Obesity Pharmacotherapy Review

A broader clinical review including randomized trials of AOD-9604.

Journal of Endocrinology & Metabolism - Safety & Tolerability

Summary of human clinical safety data for AOD-9604 (randomized trials).

Therapeutic Peptides in Orthopaedics

Meta-analysis covering AOD-9604 effects on metabolism and cartilage in research contexts.

Wikipedia - AOD9604 Overview

A neutral summary of the peptide’s structure, mechanism, clinical data, and development status.

Obesity Drugs in Clinical Development

Review including AOD-9604 among compounds under investigation for adipose metabolism.

DrugBank - AOD9604 Entry

DrugBank database entry noting AOD-9604’s status, structure, and investigational context.